Israel's fastest growing startup ecosystem
The more than 100 high-tech companies involved in R&D concentrated in Yokneam export nearly $6 billion of technology and high tech products a year. "National Priority Area A" investment grants and tax benefits, lower housing prices and its village-like surroundings make it easier for companies to grow from startup to mature companies in Yokneam without losing key personnel.
While Tel-Aviv is more oriented to the young entrepreneurs who have not yet settled down, Yokneam attracts the seasoned entrepreneurs and high tech professionals needed for longer term R&D in industries like: Medical Devices, Pharmacology, Surgical Equipment, Water Technology, Homeland Security, Electro-Optics and Image Recognition, Industrial Tools and Processes, Semiconductors and Network Infrastructure.
Yokneam's proximity to the Technion and University of Haifa, combined with the natural laboratory of its surroundings has made it a magnet for the development of new and hybrid technologies in sectors like: Internet of Things (IoT), Business Management, eCommerce and as a Service (_aaS) technologies, and technologies that can't yet be classified.
FundinG
In addition to the "National Priority A Area" investment grants and tax benefits of up to 20%, funding for startups is readily available in Yokneam.
More than one-third of NHS mental health trusts across the United Kingdom have now adopted PixCell Medical's HemoScreen point-of-care complete blood count (CBC) analyzer, marking one of the fastest known expansions of near-patient hematology within UK mental health services. Initially introduced through targeted evaluations and clozapine monitoring pilots, HemoScreen has rapidly expanded into routine clinical practice across community mental health clinics, inpatient wards and secure psychiatric units.
InMode Ltd. has called its annual general meeting for July 30, 2026, at 17:00 Israel time in Yokneam. Shareholders will vote on four items: re-electing Class I director Dr. Hadar Ron, re-appointing PwC as auditor for 2026, granting a total of 6,000 restricted share units to three non-executive directors, and approving the compensation terms for a special board committee that evaluated a potential sale process.